well if there is any bearish news on anacetrabip i would think it is bullish for amrn. as amrn has the only approved cardio drug approved this year. big pharma needs reshelving the pipeline imho.
but after reading the anacetrabip news i am not so sure this is bearish?
Market Data 
Markets 
AI
